Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
Public ClinicalTrials.gov record NCT00026338. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Placebo Controlled Study Of OSI-774 (TARCEVA) Plus Gemcitabine In Patients With Locally Advanced, Unresectable Or Metastatic Pancreatic Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Biological therapies such as erlotinib use different ways to stimulate the immune system and stop cancer cells from growing. Combining chemotherapy and biological therapy may kill more tumor cells. It is not yet known if gemcitabine is more effective with or without erlotinib in treating pancreatic cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of gemcitabine with and without erlotinib in treating patients who have unresectable locally advanced or metastatic pancreatic cancer.
Study identification
- NCT ID
- NCT00026338
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 569 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 120 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2001 (Actual)
- Primary completion
- Sep 17, 2004 (Actual)
- Completion
- Feb 10, 2009 (Actual)
- Last update posted
- Apr 2, 2020
2001 – 2009
United States locations
- U.S. sites
- 74
- U.S. states
- 32
- U.S. cities
- 66
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Clinical Research Center | Tucson | Arizona | 85712 | — |
| Highlands Oncology Group | Springdale | Arkansas | 72764 | — |
| Alta Bates Comprehensive Cancer Center | Berkeley | California | 94704 | — |
| Sutter Health West Cancer Research Group | Greenbrae | California | 94904 | — |
| Loma Linda University Cancer Institute | Loma Linda | California | 92354 | — |
| USC/Norris Comprehensive Cancer Center and Hospital | Los Angeles | California | 90033-0804 | — |
| Kenmar Research Institute | Los Angeles | California | 90057 | — |
| Century City Hospital | Los Angeles | California | 90067 | — |
| David Geffen School of Medicine | Los Angeles | California | 90095-7059 | — |
| Kaiser Permanente Medical Center/Kaiser Foundation Hospital - San Diego | San Diego | California | 92120 | — |
| Davis, Posteraro, & Wasser, MDs, LLP | Manchester | Connecticut | 06040 | — |
| New Britain General Hospital | New Britain | Connecticut | 06050-2000 | — |
| Eastern Connecticut Hematology and Oncology Associates | Norwich | Connecticut | 06360 | — |
| Hematology Oncology, P.C. | Stamford | Connecticut | 06902 | — |
| Florida Cancer Specialists | Fort Myers | Florida | 33901 | — |
| Oncology-Hematology Group of South Florida | Miami | Florida | 33176 | — |
| Ocala Oncology Center | Ocala | Florida | 34471-5563 | — |
| Oncology & Hematology Associates of West Broward | Tamarac | Florida | 33321 | — |
| Moffitt Clinic at Tampa General Hospital | Tampa | Florida | 33612-9497 | — |
| Central Georgia Hematology Oncology, P.C. | Macon | Georgia | 31201 | — |
| Mountain States Tumor Institute | Boise | Idaho | 83712 | — |
| Northwest Medical Specialists, P.C. | Arlington Heights | Illinois | 60004 | — |
| Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital) | Hines | Illinois | 60141 | — |
| Oncology/Hematology Associates of Central Illinois, P.C. | Peoria | Illinois | 61602 | — |
| Midwest Cancer Research Group, Inc. | Skokie | Illinois | 60076 | — |
| Carle Cancer Center | Urbana | Illinois | 61801 | — |
| Medical Consultants | Muncie | Indiana | 47304 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160-7353 | — |
| Lucille Parker Markey Cancer Center, University of Kentucky | Lexington | Kentucky | 40536-0093 | — |
| Norton Healthcare Pavilion | Louisville | Kentucky | 40202 | — |
| Mary Bird Perkins Cancer Center | Baton Rouge | Louisiana | 70809 | — |
| Not listed | Metairie | Louisiana | 70006 | — |
| Tulane Cancer Center | New Orleans | Louisiana | 70112-2699 | — |
| Annapolis Medical Specialists | Annapolis | Maryland | 21401 | — |
| Sinai Hospital of Baltimore | Baltimore | Maryland | 21215 | — |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore | Maryland | 21231 | — |
| Tuft-New England Medical Center | Boston | Massachusetts | 02111 | — |
| St. Elizabeth's Medical Center | Boston | Massachusetts | 02135-2997 | — |
| Berkshire Physicians and Surgeons, P.C. | Pittsfield | Massachusetts | 01201 | — |
| Baystate Medical Center | Springfield | Massachusetts | 01199 | — |
| University of Minnesota Cancer Center | Minneapolis | Minnesota | 55455 | — |
| Midwest Oncology Consortium | Kansas City | Missouri | 64111 | — |
| New Hampshire Oncology-Hematology PA | Hooksett | New Hampshire | 03106 | — |
| St. Barnabas Medical Center | Livingston | New Jersey | 07039 | — |
| Hematology-Oncology Associates | Mount Holly | New Jersey | 08060 | — |
| Cooper Cancer Institute | Voorhees Township | New Jersey | 08043 | — |
| Cancer Center at Glens Falls Hospital | Glens Falls | New York | 12801 | — |
| Arena Oncology Associates | Great Neck | New York | 11021 | — |
| NYU School of Medicine's Kaplan Comprehensive Cancer Center | New York | New York | 10016 | — |
| Beth Israel Medical Center | New York | New York | 10019 | — |
| Interlakes Oncology/Hematology PC | Rochester | New York | 14623 | — |
| Staten Island University Hospital | Staten Island | New York | 10305 | — |
| University Hospital - Stony Brook | Stony Brook | New York | 11794-8174 | — |
| Presbyterian Hospital | Charlotte | North Carolina | 28233-3549 | — |
| Mid Dakota Clinic, P.C. | Bismarck | North Dakota | 58502-5538 | — |
| University Hospitals of Cleveland | Cleveland | Ohio | 44106 | — |
| Earle A. Chiles Research Institute at Providence Portland Medical Center | Portland | Oregon | 97213-2967 | — |
| Hematology-Oncology Association of NE Pennsylvania | Dunmore | Pennsylvania | 18512 | — |
| University of Pennsylvania Cancer Center | Philadelphia | Pennsylvania | 19104 | — |
| Pennsylvania Oncology Hematology Associates | Philadelphia | Pennsylvania | 19106 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| Charleston Hematology-Oncology, P.A. | Charleston | South Carolina | 29403 | — |
| Sarah Cannon-Minnie Pearl Cancer Center | Nashville | Tennessee | 37203 | — |
| Arlington Cancer Center | Arlington | Texas | 76012 | — |
| Southwest Regional Cancer Center | Austin | Texas | 78705 | — |
| Texas Cancer Care | Fort Worth | Texas | 76104 | — |
| University of Texas - MD Anderson Cancer Center | Houston | Texas | 77030-4009 | — |
| Tyler Hematology Oncology, P.A. | Tyler | Texas | 75701 | — |
| Green Mountain Oncology Group | Bennington | Vermont | 05201 | — |
| Hematology & Oncology Associates of Virginia | Mechanicsville | Virginia | 23116 | — |
| Western Washington Oncology | Olympia | Washington | 98502 | — |
| Southwest Washington Medical Center | Vancouver | Washington | 98664 | — |
| Oncology of Wisconsin | Glendale | Wisconsin | 53212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 99 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00026338, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 2, 2020 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00026338 live on ClinicalTrials.gov.